Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $25.74 and last traded at $25.76, with a volume of 63285 shares changing hands. The stock had previously closed at $26.25. Analyst Upgrades and Downgrades A number of equities research analysts have commented […]
Gotham Asset Management LLC boosted its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 16.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 22,317 shares of the company’s stock after acquiring an additional 3,203 shares during the period. Gotham Asset Management LLC’s holdings in Pacira BioSciences were worth […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Zacks Research dropped their Q1 2025 earnings estimates for Pacira BioSciences in a research report issued to clients and investors on Friday, February 23rd. Zacks Research analyst R. Department now expects that the company will post earnings of $0.69 per share for the quarter, down from their […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Research analysts at Zacks Research reduced their Q1 2025 EPS estimates for shares of Pacira BioSciences in a research note issued to investors on Friday, February 23rd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.69 for the quarter, […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Equities research analysts at Zacks Research decreased their Q3 2024 earnings per share estimates for Pacira BioSciences in a note issued to investors on Wednesday, February 21st. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.59 for the quarter, […]